Attia MW, Klein JD, Zaoutis T: Does a Day Make a Difference? Duration of Illness and Clinical Presentation of Group A beta-hemolytic streptococcal pharyngitis in children. [Infectious Diseases in Clinical Practice] 11(7): 381-384, Jun 1905
Zaoutis T, Moore LS, Furness K, Klein JD: In vitro activities of linezolid, meropenem, and quinupristin-dalfopristin against group C and G streptococci, including vancomycin-tolerant isolates. [Antimicrob Agents Chemother] 45: 1952-54, Jun 1905
Hyle EP, Lipworth AD, Zaoutis TE, Nachamkin I, Bilker WB, Lautenbach E: Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum beta-lactamase-producing enterobacteriaceae: variability by site of infection. [Arch Intern Med] 165(12): 1375-80, Jun 2005
Hyle EP, Lipworth AD, Zaoutis TE, Nachamkin I, Fishman NO, Bilker WB, Mao X, Lautenbach E: Risk factors for increasing multi-drug resistance among extended spectrum beta-lactamase-producing Escherichia coli and Klebsiella species. [Clin Infect Dis] 40: 1317-24, May 2005
Page
64
| 68